Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-51158
Open Biol 2015 Aug 01;58:. doi: 10.1098/rsob.150063.
Show Gene links Show Anatomy links

Short linear motif acquisition, exon formation and alternative splicing determine a pathway to diversity for NCoR-family co-repressors.

Short S , Peterkin T , Guille M , Patient R , Sharpe C .


???displayArticle.abstract???
Vertebrate NCoR-family co-repressors play central roles in the timing of embryo and stem cell differentiation by repressing the activity of a range of transcription factors. They interact with nuclear receptors using short linear motifs (SLiMs) termed co-repressor for nuclear receptor (CoRNR) boxes. Here, we identify the pathway leading to increasing co-repressor diversity across the deuterostomes. The final complement of CoRNR boxes arose in an ancestral cephalochordate, and was encoded in one large exon; the urochordates and vertebrates then split this region between 10 and 12 exons. In Xenopus, alternative splicing is prevalent in NCoR2, but absent in NCoR1. We show for one NCoR1 exon that alternative splicing can be recovered by a single point mutation, suggesting NCoR1 lost the capacity for alternative splicing. Analyses in Xenopus and zebrafish identify that cellular context, rather than gene sequence, predominantly determines species differences in alternative splicing. We identify a pathway to diversity for the NCoR family beginning with the addition of a SLiM, followed by gene duplication, the generation of alternatively spliced isoforms and their differential deployment.

???displayArticle.pubmedLink??? 26289800
???displayArticle.pmcLink??? PMC4554918
???displayArticle.link??? Open Biol
???displayArticle.grants??? [+]

Species referenced: Xenopus laevis
Genes referenced: ncor1 ncor2


???attribute.lit??? ???displayArticles.show???
References [+] :
Alrfaei, microRNA-100 targets SMRT/NCOR2, reduces proliferation, and improves survival in glioblastoma animal models. 2013, Pubmed